151 related articles for article (PubMed ID: 20157292)
1. Impairment of ultrastructure and cytoskeleton during progression of cardiac hypertrophy to heart failure.
Gupta A; Gupta S; Young D; Das B; McMahon J; Sen S
Lab Invest; 2010 Apr; 90(4):520-30. PubMed ID: 20157292
[TBL] [Abstract][Full Text] [Related]
2. Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.
Das B; Young D; Vasanji A; Gupta S; Sarkar S; Sen S
Cardiovasc Res; 2010 Aug; 87(3):524-34. PubMed ID: 20202977
[TBL] [Abstract][Full Text] [Related]
3. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure.
Sarkar S; Chawla-Sarkar M; Young D; Nishiyama K; Rayborn ME; Hollyfield JG; Sen S
J Biol Chem; 2004 Dec; 279(50):52630-42. PubMed ID: 15385543
[TBL] [Abstract][Full Text] [Related]
4. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha.
Janczewski AM; Kadokami T; Lemster B; Frye CS; McTiernan CF; Feldman AM
Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H960-9. PubMed ID: 12578819
[TBL] [Abstract][Full Text] [Related]
5. The end-stage failing human myocardium - Where changes in ultrastructure of human cardiac muscle cells do not appear to dictate clinical outcomes.
Varga I; Galfiova P; Gazova A; Barczi T; Polak S; Danisovic L; Hulman M; Kyselovic J
Med Hypotheses; 2018 Jan; 110():105-109. PubMed ID: 29317051
[TBL] [Abstract][Full Text] [Related]
6. CaMKIIδC Drives Early Adaptive Ca
Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
[TBL] [Abstract][Full Text] [Related]
7. Desmin loss and mitochondrial damage precede left ventricular systolic failure in volume overload heart failure.
Guichard JL; Rogowski M; Agnetti G; Fu L; Powell P; Wei CC; Collawn J; Dell'Italia LJ
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H32-H45. PubMed ID: 28455287
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte mitochondrial oxidative stress and cytoskeletal breakdown in the heart with a primary volume overload.
Yancey DM; Guichard JL; Ahmed MI; Zhou L; Murphy MP; Johnson MS; Benavides GA; Collawn J; Darley-Usmar V; Dell'Italia LJ
Am J Physiol Heart Circ Physiol; 2015 Mar; 308(6):H651-63. PubMed ID: 25599572
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement.
Weisleder N; Soumaka E; Abbasi S; Taegtmeyer H; Capetanaki Y
J Mol Cell Cardiol; 2004 Jan; 36(1):121-8. PubMed ID: 14734054
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
[TBL] [Abstract][Full Text] [Related]
11. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
[TBL] [Abstract][Full Text] [Related]
12. Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy.
Gupta S; Maitra R; Young D; Gupta A; Sen S
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H627-36. PubMed ID: 19502558
[TBL] [Abstract][Full Text] [Related]
13. Mice expressing L345P mutant desmin exhibit morphological and functional changes of skeletal and cardiac mitochondria.
Kostareva A; Sjöberg G; Bruton J; Zhang SJ; Balogh J; Gudkova A; Hedberg B; Edström L; Westerblad H; Sejersen T
J Muscle Res Cell Motil; 2008; 29(1):25-36. PubMed ID: 18563598
[TBL] [Abstract][Full Text] [Related]
14. Alterations in Multi-Scale Cardiac Architecture in Association With Phosphorylation of Myosin Binding Protein-C.
Taylor EN; Hoffman MP; Barefield DY; Aninwene GE; Abrishamchi AD; Lynch TL; Govindan S; Osinska H; Robbins J; Sadayappan S; Gilbert RJ
J Am Heart Assoc; 2016 Mar; 5(3):e002836. PubMed ID: 27068630
[TBL] [Abstract][Full Text] [Related]
15. Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice.
Sarkar S; Leaman DW; Gupta S; Sil P; Young D; Morehead A; Mukherjee D; Ratliff N; Sun Y; Rayborn M; Hollyfield J; Sen S
J Biol Chem; 2004 May; 279(19):20422-34. PubMed ID: 14970239
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural morphometric findings of cardiomyocytes in patients with impaired ventricular function--a comparative clinicopathological study.
Wassilew K; Terziev D; Wassilew G; Fitzl G; Frölich K; Kandolf R; Fried A
Cardiovasc Pathol; 2016; 25(1):25-32. PubMed ID: 26472277
[TBL] [Abstract][Full Text] [Related]
17. [Interconnection of parameters of the mitochondrial and myofibrillar apparatus of cardiomyocytes and ploidy and hypertrophy in certain mammalian species, differing in body mass].
Kudriavtsev BN; Anatskaia OV; Nilova VK; Komarov SA
Tsitologiia; 1997; 39(10):946-64. PubMed ID: 9505342
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative ultrastructural characteristics of mitochondria and myofibrils in the myocardium in chronic hemodynamic overload].
Lukáciková E; Fízel' A; Fízel'ová A; Bózner A
Cesk Patol; 1989 Nov; 25(4):230-5. PubMed ID: 2534287
[TBL] [Abstract][Full Text] [Related]
19. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
